- Home
- TYGO vs MDAI Comparison
TYGO vs MDAI Comparison
Compare TYGO & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- MDAI
- Stock Information
- Founded
- TYGO 2007
- MDAI 2013
- Country
- TYGO United States
- MDAI United States
- Employees
- TYGO N/A
- MDAI N/A
- Industry
- TYGO Semiconductors
- MDAI Medical/Dental Instruments
- Sector
- TYGO Technology
- MDAI Health Care
- Exchange
- TYGO Nasdaq
- MDAI Nasdaq
- Market Cap
- TYGO 82.5M
- MDAI 69.0M
- IPO Year
- TYGO N/A
- MDAI N/A
- Fundamental
- Price
- TYGO $1.25
- MDAI $2.60
- Analyst Decision
- TYGO Strong Buy
- MDAI Strong Buy
- Analyst Count
- TYGO 2
- MDAI 2
- Target Price
- TYGO $3.75
- MDAI $4.75
- AVG Volume (30 Days)
- TYGO 55.1K
- MDAI 787.8K
- Earning Date
- TYGO 07-29-2025
- MDAI 08-11-2025
- Dividend Yield
- TYGO N/A
- MDAI N/A
- EPS Growth
- TYGO N/A
- MDAI N/A
- EPS
- TYGO N/A
- MDAI N/A
- Revenue
- TYGO $63,051,000.00
- MDAI $29,962,000.00
- Revenue This Year
- TYGO $69.44
- MDAI N/A
- Revenue Next Year
- TYGO $21.75
- MDAI $15.15
- P/E Ratio
- TYGO N/A
- MDAI N/A
- Revenue Growth
- TYGO N/A
- MDAI 55.21
- 52 Week Low
- TYGO $0.58
- MDAI $0.82
- 52 Week High
- TYGO $1.80
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- TYGO 48.66
- MDAI 54.14
- Support Level
- TYGO $1.27
- MDAI $2.43
- Resistance Level
- TYGO $1.36
- MDAI $2.75
- Average True Range (ATR)
- TYGO 0.10
- MDAI 0.21
- MACD
- TYGO -0.01
- MDAI -0.06
- Stochastic Oscillator
- TYGO 22.22
- MDAI 29.07
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.